药代动力学
医学
耐受性
药理学
最大值
打开标签
不利影响
药效学
口服
Cmin公司
交叉研究
内科学
泊沙康唑
生物利用度
胃肠病学
作者
Wei Ji,Hengli Zhao,Shaomei Yang,Qing Wen,Kun He
摘要
Posaconazole is a triazole antifungal drug with strong antifungal effect. The pharmacokinetics, safety, and tolerability were evaluated following the intravenous administration of posaconazole injection. A total of 36 healthy adults were enrolled in the parallel-designed clinical trial, and the subjects received single doses of posaconazole injection (100, 200 and 300 mg). Posaconazole concentrations in plasma were determined with liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. The levels of posaconazole in plasma increased proportionally between 100 and 300-mg dose, but AUC showed a more-than-dose-proportional increase. Besides, decreased Vd and CL were observed, along with the increased posaconazole dosage. Posaconazole was well tolerated at all dose levels, and the adverse events were not dose dependent. No clinically significant changes in electrocardiograms were observed.
科研通智能强力驱动
Strongly Powered by AbleSci AI